Tenet Healthcare (THC)
(Delayed Data from NYSE)
$156.57 USD
-0.17 (-0.11%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $156.69 +0.12 (0.08%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for Tenet Healthcare Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1,311.00 | 1,001.00 | 1,476.00 | 768.00 | 154.00 |
Depreciation/Amortization & Depletion | 902.00 | 874.00 | 888.00 | 895.00 | 885.00 |
Net Change from Assets/Liabilities | 71.00 | -1,143.00 | -737.00 | 1,592.00 | -294.00 |
Net Cash from Discontinued Operations | 0.00 | -2.00 | 1.00 | -1.00 | -20.00 |
Other Operating Activities | 90.00 | 353.00 | -60.00 | 153.00 | 508.00 |
Net Cash From Operating Activities | 2,374.00 | 1,083.00 | 1,568.00 | 3,407.00 | 1,233.00 |
Property & Equipment | -751.00 | -762.00 | -658.00 | -540.00 | -670.00 |
Acquisition/ Disposition of Subsidiaries | -224.00 | -234.00 | -1,220.00 | -1,177.00 | -8.00 |
Investments | 17.00 | 194.00 | 1,171.00 | 92.00 | 83.00 |
Other Investing Activities | -11.00 | -6.00 | -7.00 | 17.00 | -24.00 |
Net Cash from Investing Activities | -969.00 | -808.00 | -714.00 | -1,608.00 | -619.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -367.00 | -350.00 | -27.00 | -16.00 | 1.00 |
Issuance (Repayment) of Debt | -172.00 | -828.00 | -349.00 | 525.00 | -412.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -594.00 | -560.00 | -423.00 | -287.00 | -307.00 |
Other Financing Activities | 98.00 | -43.00 | -137.00 | 163.00 | -45.00 |
Net Cash from Financing Activities | -1,035.00 | -1,781.00 | -936.00 | 385.00 | -763.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 370.00 | -1,506.00 | -82.00 | 2,184.00 | -149.00 |
Cash at Beginning of Period | 858.00 | 2,364.00 | 2,446.00 | 262.00 | 411.00 |
Cash at End of Period | 1,228.00 | 858.00 | 2,364.00 | 2,446.00 | 262.00 |
Diluted Net EPS | 5.71 | 3.79 | 8.42 | 3.75 | -2.24 |
Fiscal Year End for Tenet Healthcare Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2,811.00 | 2,334.00 | 1,311.00 | 855.00 | 589.00 |
Depreciation/Amortization & Depletion | 430.00 | 216.00 | 902.00 | 679.00 | 448.00 |
Net Change from Assets/Liabilities | 705.00 | 545.00 | 71.00 | -92.00 | -20.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -2,613.00 | -2,509.00 | 90.00 | 108.00 | 30.00 |
Net Cash From Operating Activities | 1,333.00 | 586.00 | 2,374.00 | 1,550.00 | 1,047.00 |
Property & Equipment | -385.00 | -240.00 | -751.00 | -543.00 | -367.00 |
Acquisition/ Disposition of Subsidiaries | -510.00 | -449.00 | -224.00 | -70.00 | -96.00 |
Investments | 4,039.00 | 4,027.00 | 17.00 | -16.00 | 5.00 |
Other Investing Activities | -10.00 | -10.00 | -11.00 | -7.00 | -9.00 |
Net Cash from Investing Activities | 3,134.00 | 3,328.00 | -969.00 | -636.00 | -467.00 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -636.00 | -330.00 | -367.00 | -217.00 | -169.00 |
Issuance (Repayment) of Debt | -2,171.00 | -2,139.00 | -172.00 | -110.00 | -75.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -323.00 | -162.00 | -594.00 | -425.00 | -270.00 |
Other Financing Activities | 315.00 | -30.00 | 98.00 | 34.00 | 10.00 |
Net Cash from Financing Activities | -2,815.00 | -2,661.00 | -1,035.00 | -718.00 | -504.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1,652.00 | 1,253.00 | 370.00 | 196.00 | 76.00 |
Cash at Beginning of Period | 1,228.00 | 1,228.00 | 858.00 | 858.00 | 858.00 |
Cash at End of Period | 2,880.00 | 2,481.00 | 1,228.00 | 1,054.00 | 934.00 |
Diluted Net EPS | 2.64 | 21.38 | 2.30 | 0.94 | 1.15 |